reference/31163351

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31163351

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	1932-6203
issueIdentifier	6
pageRange	e0253487-
publicationName	PLOS ONE
startingPage	e0253487
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_125afde58459cb2cf5757e0bc9864e2c
bibliographicCitation	Chan CEZ, Seah SGK, Chye DH, Massey S, Torres M, Lim APC, Wong SKK, Neo JJY, Wong PS, Lim JH, Loh GSL, Wang D, Boyd-Kirkup JD, Guan S, Thakkar D, Teo GH, Purushotorman K, Hutchinson PE, Young BE, Low JG, MacAry PA, Hentze H, Prativadibhayankara VS, Ethirajulu K, Comer JE, Tseng CK, Barrett ADT, Ingram PJ, Brasel T, Hanson BJ. The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody. PLoS ONE. 2021 Jun 23;16(6):e0253487. doi: 10.1371/journal.pone.0253487.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36f02adb1435deb7523280b7d2553adf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad271dd707d3314a584eb5a78c594225 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c61294ba7e3f6ed8f2f725d0e0c29c01 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f04243833a9a9e67b78841b80111e58 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1ef599993fb1658b850bd0356c0a73c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6281201885bdfb1509f7388fbfd93837 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8fac1438e0624b64f6c1997a0233c87 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba0d546f35afb5ffef8e068b8567793a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8752-2650 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd240a0ae9ff5c733fda1db60356edeb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_485bea9d6e99e4af4085b9d77d0697b8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_02d3274074c92a4f4a542f3a3e8dd875 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc3b53bd503c8b109d4066bd529d5703 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d6551ccaf0f64350ec21b1a1f621e20 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66b693eef73a4d869a28c13a936e3248 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd369712c85d825e05842e386d4d82fa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c4b1742715f56c7c8b6a79aa9423622 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4675423fb54cf024187398cca5ff02ab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e1081a9a91d1e0feec6edd3074cae23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd8b07766dc2efc09899713c571e0510 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef592a75a5adc07ef7ca73a5f37ad383 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9cf51a60b9310e66a3031cbd6539206a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64fc53751b29cc8c073e8f92c04302b5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7379c10010465fb72737f58c63e1033 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aaba59202fea6433e685e38b93032439 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f022270f021b63b288d1bcbda468b341 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0d692626bfa8d7668e738f0055637e2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e6ec1e41eb5e7fda1a705b6048a83d83 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_893424979e492ed0a14b38b7f3540cd1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e40091ecb5dd35c68a08ffa02830bfcb
date	2021-06-23^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC8221499 https://doi.org/10.1371/journal.pone.0253487 https://pubmed.ncbi.nlm.nih.gov/34161386
isPartOf	https://portal.issn.org/resource/ISSN/1932-6203 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33103
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody
discusses	http://id.nlm.nih.gov/mesh/M0581462 http://id.nlm.nih.gov/mesh/M0376295 http://id.nlm.nih.gov/mesh/M000683757 http://id.nlm.nih.gov/mesh/M0489621 http://id.nlm.nih.gov/mesh/M0028294 http://id.nlm.nih.gov/mesh/M0011127 http://id.nlm.nih.gov/mesh/M0534745 http://id.nlm.nih.gov/mesh/M0370114 http://id.nlm.nih.gov/mesh/M0024747
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000086402Q000276 http://id.nlm.nih.gov/mesh/D057134Q000494 http://id.nlm.nih.gov/mesh/D057134Q000276 http://id.nlm.nih.gov/mesh/D000086382Q000628
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D007074Q000302 http://id.nlm.nih.gov/mesh/D019562 http://id.nlm.nih.gov/mesh/D000085962Q000235 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D064370Q000378 http://id.nlm.nih.gov/mesh/D000086382Q000276 http://id.nlm.nih.gov/mesh/D007074Q000276 http://id.nlm.nih.gov/mesh/D007141Q000276 http://id.nlm.nih.gov/mesh/D016207Q000097 http://id.nlm.nih.gov/mesh/D018925Q000097 http://id.nlm.nih.gov/mesh/D006224 http://id.nlm.nih.gov/mesh/D008253 http://id.nlm.nih.gov/mesh/D004195 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D003289 http://id.nlm.nih.gov/mesh/D002522 http://id.nlm.nih.gov/mesh/D057134Q000378 http://id.nlm.nih.gov/mesh/D016207Q000235 http://id.nlm.nih.gov/mesh/D008822 http://id.nlm.nih.gov/mesh/D018925Q000235 http://id.nlm.nih.gov/mesh/D014709 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000086382Q000821
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ea0a8c09a066eaed63255bcd356cb0ca http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6762 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9710

Showing number of triples: 1 to 89 of 89.